Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v9-EN
Language French English
Date Updated 2021-03-19 2021-03-19
Drug Identification Number 02237923 02237923
Brand name AVAPRO AVAPRO
Common or Proper name Avapro Avapro
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients IRBESARTAN IRBESARTAN
Strength(s) 75MG 75MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90 90
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-04-21 2021-04-21
Actual start date
Estimated end date 2021-06-30 2021-06-30
Actual end date 2021-03-19 2021-03-19
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments Shortage avoided Shortage avoided
Health Canada comments